PT1137438E - Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos - Google Patents

Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos

Info

Publication number
PT1137438E
PT1137438E PT99961041T PT99961041T PT1137438E PT 1137438 E PT1137438 E PT 1137438E PT 99961041 T PT99961041 T PT 99961041T PT 99961041 T PT99961041 T PT 99961041T PT 1137438 E PT1137438 E PT 1137438E
Authority
PT
Portugal
Prior art keywords
prepared
improved therapeutic
containing nucleotides
synthetic inhibitors
therapeutic spectrum
Prior art date
Application number
PT99961041T
Other languages
English (en)
Inventor
Jurgen Lindner
Burkhard Haase
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1137438E publication Critical patent/PT1137438E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99961041T 1998-12-10 1999-12-01 Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos PT1137438E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19857009A DE19857009A1 (de) 1998-12-10 1998-12-10 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren

Publications (1)

Publication Number Publication Date
PT1137438E true PT1137438E (pt) 2002-11-29

Family

ID=7890633

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99961041T PT1137438E (pt) 1998-12-10 1999-12-01 Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos

Country Status (30)

Country Link
EP (1) EP1137438B1 (pt)
JP (1) JP2002531525A (pt)
KR (1) KR20010080729A (pt)
CN (1) CN1189214C (pt)
AR (1) AR021577A1 (pt)
AT (1) ATE218370T1 (pt)
AU (1) AU766810B2 (pt)
BG (1) BG105548A (pt)
BR (1) BR9916006A (pt)
CA (1) CA2354266A1 (pt)
CZ (1) CZ20012029A3 (pt)
DE (2) DE19857009A1 (pt)
DK (1) DK1137438T3 (pt)
EA (1) EA005136B1 (pt)
EE (1) EE200100305A (pt)
ES (1) ES2178496T3 (pt)
HK (1) HK1041598B (pt)
HR (1) HRP20010429A2 (pt)
HU (1) HUP0104624A3 (pt)
IL (1) IL143586A0 (pt)
MX (1) MXPA01005861A (pt)
NO (1) NO20012719L (pt)
NZ (1) NZ511882A (pt)
PL (1) PL349336A1 (pt)
PT (1) PT1137438E (pt)
SI (1) SI1137438T1 (pt)
SK (1) SK284842B6 (pt)
WO (1) WO2000033876A1 (pt)
YU (1) YU39901A (pt)
ZA (1) ZA200104815B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072527A2 (de) * 2001-03-13 2002-09-19 Protagen Aktiengesellschaft 1-butansäurederivate wie z.b. carbomethoxypropionylcyanid oder leflunomidderivate und deren therapeutische anwendung
DE10112924A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2004012746A2 (en) * 2002-08-02 2004-02-12 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
JP2005538165A (ja) * 2002-09-06 2005-12-15 シェボ ビオテック アクティエン ゲゼルシャフト 解糖酵素及び/又はアミノ基転移酵素錯体調節用化合物
JPWO2005060980A1 (ja) * 2003-12-24 2007-12-13 正彬 少名子 疾患治療用医薬及び糖尿病治療用医薬
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
MX2009011816A (es) 2007-05-03 2009-11-19 Pfizer Ltd Derivados de piridina.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
IT1254519B (it) * 1992-03-16 1995-09-25 Chiesi Farma Spa Associazioni di composti ad attivita' antivirale
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
AU4596097A (en) * 1996-09-26 1998-04-17 Williams, James W. Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives

Also Published As

Publication number Publication date
SK284842B6 (sk) 2005-12-01
CN1189214C (zh) 2005-02-16
ATE218370T1 (de) 2002-06-15
CN1329506A (zh) 2002-01-02
MXPA01005861A (es) 2002-03-27
DE59901681D1 (de) 2002-07-11
IL143586A0 (en) 2002-04-21
CZ20012029A3 (cs) 2002-02-13
AU1779300A (en) 2000-06-26
DE19857009A1 (de) 2000-06-15
EP1137438A1 (de) 2001-10-04
ES2178496T3 (es) 2002-12-16
NO20012719D0 (no) 2001-06-01
BR9916006A (pt) 2001-09-04
SI1137438T1 (en) 2002-08-31
JP2002531525A (ja) 2002-09-24
EA005136B1 (ru) 2004-12-30
NZ511882A (en) 2003-11-28
CA2354266A1 (en) 2000-06-15
HK1041598A1 (en) 2002-07-12
HK1041598B (zh) 2005-07-15
EA200100647A1 (ru) 2001-12-24
NO20012719L (no) 2001-06-01
ZA200104815B (en) 2002-06-13
BG105548A (en) 2001-12-29
PL349336A1 (en) 2002-07-15
AU766810B2 (en) 2003-10-23
SK7882001A3 (en) 2001-12-03
WO2000033876A1 (de) 2000-06-15
EE200100305A (et) 2002-08-15
HRP20010429A2 (en) 2002-06-30
HUP0104624A3 (en) 2002-12-28
DK1137438T3 (da) 2002-10-14
AR021577A1 (es) 2002-07-24
KR20010080729A (ko) 2001-08-22
YU39901A (sh) 2005-06-10
HUP0104624A2 (hu) 2002-04-29
EP1137438B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
PT1114033E (pt) 4-carboxiamino-2-metil-1,2,3,4-tetra-hidroquinolinas como inibidores de cetp
CU23082A3 (es) 4-carboxiamino-2-subsituidos-1,2,3,4- tetrahidroquinolas como inhibidores cetp
NO20011359L (no) Syntaser
BR9816191B1 (pt) unidade de ampola/portador.
BR9909681B1 (pt) estrutura de seringa.
PT1007520E (pt) 2-aminopiridinas contendo substituintes com aneis condensados como inibidores de nos
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
IS4565A (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
DE69922494D1 (de) Zyklische n-acylamin-derivate
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
DE69817792D1 (de) 16-hydroxy-11-(substituierte phenyl)-estra-4,9-dien derivate
EE200100174A (et) 1-desoksü-D-ksüluloosi biosünteesiraja geenid
DE60029283D1 (de) Selenchelatbildner enthaltendes Düngemittel
PT1137438E (pt) Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
BR0012043B1 (pt) composiÇço de tratamento de cabelo.
DE50010538D1 (de) Mehrkanal-Tropfengenerator
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
PT1077945E (pt) Isoquinolinas como inibidores de uroquinase
EE200000179A (et) 1-oxa, aza ja tianaftaleen-2-1 biseetrid fosfolambaani inhibiitoritena
DE69910683D1 (de) Sähmaschine
NO20006314D0 (no) Prenyltransferase-inhibitorer
BR9804596B1 (pt) composiÇço cosmÉtica bifÁsica.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
PT1115708E (pt) Derivados aminoalquil-3,4-di-hidroquinolina como inibidores da sintetase do no